Vaccination strategies to enhance immunity in neonates

Tobias R Kollmann1, Arnaud Marchant2, Sing Sing Way3

  • 1Systems Vaccinology, Telethon Kids Institute, Nedlands, WA 6009, Australia. tobias.kollmann@telethonkids.org.au marchant@ulb.be singsing.way@cchmc.org.

Science (New York, N.Y.)
|May 9, 2020
PubMed

Insights

Neonates face high infection risks. New vaccine strategies, including maternal vaccination and broad immune stimulation, aim to protect newborns during their vulnerable early weeks of life.

Area of Science:

  • Immunology
  • Neonatal Health
  • Vaccinology

Background:

  • Neonates are highly susceptible to infections, posing a significant global health challenge.
  • Current vaccines often do not cover prevalent neonatal pathogens or elicit timely protection due to developmental immaturity.
  • The window of vulnerability in early life necessitates novel protective strategies beyond conventional vaccination.

Purpose of the Study:

  • To explore alternative vaccination strategies for enhancing neonatal protection against infections.
  • To discuss pathogen-agnostic immune stimulation and maternal vaccination for passive immunity transfer.
  • To identify knowledge gaps and outline future research directions in neonatal vaccinology.

Main Methods:

  • Review of current literature on neonatal immunity and vaccine responses.
  • Analysis of proposed alternative strategies: pathogen-agnostic vaccination and antenatal immunization.
  • Discussion of the synergistic potential of combining maternal and neonatal vaccination approaches.

Main Results:

  • Existing vaccines are insufficient for protecting neonates against major infectious agents.
  • Maternal vaccination offers passive immunity transfer, protecting infants during their critical early period.
  • Pathogen-agnostic approaches and combined strategies show promise for broader, more immediate protection.

Conclusions:

  • Novel vaccination strategies are crucial to address the high burden of neonatal infections.
  • Maternal immunization and pathogen-agnostic approaches represent promising avenues for enhancing neonatal immunity.
  • Further research is needed to optimize and integrate these strategies for comprehensive neonatal protection.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
50.9K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
664
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.6K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
832
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172